| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Experimental Oncology A, Istituto Nazionale Tumori [D. D., M.G. B., M. A. P., D. B., M. G. R., G. D. P.], and First Clinic of Dermatology, University of Milan [E.B., R. G., E. A., R. C.], Milan, Italy
Fourteen cases of primary cutaneous B-cell lymphomas were investigated at the immunohistochemical and molecular level to further characterize this newly defined entity. Neoplastic cells from all cases, phenotyped with a panel of monoclonal antibodies, were positive for HLA-DR, for the B-cell markers CD19, CD22, but not CD23 (except one case), and negative for the T-cell marker CD2. Monoclonal immunoglobulin light chains were demonstrated in six cases. The reactivity with the Ki-67 monoclonal antibody indicated that the neoplastic cells are proliferating. In five biopsies the presence of dendritic cells infiltrating the neoplastic areas was revealed using the monoclonal antibody Kim4b.
By Southern blot analysis, clonal rearrangement of the immunoglobulin heavy chain gene (involving one or both alleles) was shown in 12 of 14 cases and of the light chain genes in 13 cases. The bcl-2 oncogene, normally involved in nodal follicular lymphomas, was in germ-line configuration. The c-myc and the ß and
chain genes of the T-cell receptor were also in the germ-line configuration. None of the cases presented Epstein-Barr virus sequences.
These data indicate that primary cutaneous lymphomas of B-cell origin share morphological and phenotypic similarities with the nodal B-cell lymphomas of follicular histotype, are proliferating, and express in 45% of cases clear monoclonal immunoglobulin light chain; the molecular analysis confirms the B-cell derivation and the monoclonal nature of this neoplasia; it also shows that neither bcl-2 nor c-myc oncogenes are involved and that no inappropriate rearrangements of the T-cell receptor genes are found in this lymphoma.
1 This work was partly supported by a grant of the Italian National Research Council, Progetto Finalizzato Oncologia (Contracts 86.00455.44 and 87.01214.44) and by the Associazione Italiana Ricerche Cancro.
2 To whom requests for reprints should be addressed, at Division of Experimental Oncology A, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy.
Received 6/10/88. Revised 1/27/89. Revised 5/18/89. Accepted 5/26/89.
This article has been cited by other articles:
![]() |
R. Bergman, P. J. Kurtin, L. E. Gibson, P. R. Hull, T. K. Kimlinger, and A. L. Schroeter Clinicopathologic, Immunophenotypic, and Molecular Characterization of Primary Cutaneous Follicular B-Cell Lymphoma Arch Dermatol, April 1, 2001; 137(4): 432 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cerroni, E. Arzberger, B. Putz, G. Hofler, D. Metze, C. A. Sander, C. Rose, P. Wolf, A. Rutten, J. M. McNiff, et al. Primary cutaneous follicle center cell lymphoma with follicular growth pattern Blood, June 15, 2000; 95(12): 3922 - 3928. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Pandolfino, R. S. Siegel, T. M. Kuzel, S. T. Rosen, and J. Guitart Primary Cutaneous B-Cell Lymphoma: Review and Current Concepts J. Clin. Oncol., May 10, 2000; 18(10): 2152 - 2168. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.H.H. Kramer, J. Hermans, E. Wijburg, K. Philippo, E. Geelen, J.H.J.M. van Krieken, D. de Jong, E. Maartense, E. Schuuring, and P.M. Kluin Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma Blood, November 1, 1998; 92(9): 3152 - 3162. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |